Long COVID syndrome, also known as post-COVID, is more than fatigue and shortness of breath. Symptoms such as headaches, brain fog and ringing in the ears have been reported, and recently, physicians are seeing more patients with gastrointestinal problems. Greg Vanichkachorn, M.D., director of Mayo Clinic’s COVID Activity Rehabilitation Program, describes the most common symptoms. Patients in the rehabilitation […]
Read More
Laboratory Studies Because the signs and symptoms of coronavirus disease 2019 (COVID-19) may overlap with those of other respiratory pathogens, it is important to perform laboratory testing to specifically identify symptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, it is estimated that up to 40% of people with SARS-CoV-2 infection […]
Read More
North Korean officials have reported a major outbreak of another infectious disease, which is affecting at least 800 families so far. Medical crews and disease investigators were sent to Haeju City in South Hwanghae province for an “acute enteric epidemic,” which refers to a digestive illness. South Korean officials have […]
Read More
The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways This study demonstrated that participants with previous SARS-CoV-2 infections had mild to moderate cognitive impairment up to 4 months after diagnosis, independently of baseline cognitive function. Mild cognitive decline is […]
Read More
U.S. Food and Drug Administration advisers say Moderna’s COVID-19 vaccine is safe and effective for children aged 6 months to 17 years, according to an FDA document made public on Friday. Two doses of the Moderna vaccine caused an immune response in clinical trial participants that was similar to the immune response […]
Read More
By testing for both SARS-CoV-2 spike and nucleocapsid antibodies, seroprevalence studies can estimate the proportion of a population with antibodies from previous infection (nucleocapsid antibody or infection-induced seroprevalence) and from infection or vaccination (spike antibody or combined infection- and vaccine-induced seroprevalence). US seroprevalence from July 2020 to May 2021 based […]
Read More
The risk of developing myocarditis and other inflammatory heart conditions after COVID-19 vaccination is substantially lower than it is after SARS-CoV-2 infection, according to an analysis of electronic health records from 40 US health systems. Although it’s a rare complication, myocarditis has been associated with both SARS-CoV-2 infection and messenger RNA (mRNA)–based […]
Read More
In a new risk-assessment document, the European Centre for Disease Prevention and Control (ECDC) summarizes what we currently know about monkeypox and recommends that European countries focus on the identification and management of the disease as well as contract tracing and prompt reporting of new cases of the virus. Recent […]
Read More
México está cerrando su ciclo epidémico y transitando al estado endémico de la pandemia de COVID-19, aseguró a finales de abril de este año el subsecretario de Salud, Hugo López-Gatell. Sin embargo, ya son 12 entidades federativas que presentan repuntes significativos, de acuerdo con Arturo Erdély, actuario y doctor en Ciencias matemáticas por la UNAM. Arturo Erdély, quien se ha dedicado al análisis estadístico de la […]
Read More
